<?xml version="1.0" encoding="UTF-8"?>
<ref id="CIT0103">
 <label>103</label>
 <mixed-citation publication-type="journal">
  <person-group person-group-type="author">
   <name name-style="western">
    <surname>Cherukupalli</surname>
    <given-names>S</given-names>
   </name>, 
   <name name-style="western">
    <surname>Chandrasekaran</surname>
    <given-names>B</given-names>
   </name>, 
   <name name-style="western">
    <surname>Krystof</surname>
    <given-names>V</given-names>
   </name>, 
   <etal>et al.</etal>
  </person-group>
  <article-title>Synthesis, anticancer evaluation, and molecular docking studies of some novel 4,6-disubstituted pyrazolo[3,4-d]pyrimidines as cyclin-dependent kinase 2 (CDK2) inhibitors</article-title>. 
  <source>Bioorg Chem</source>
  <year>2018</year>;
  <volume>79</volume>:
  <fpage>46</fpage>–
  <lpage>59</lpage>.
  <pub-id pub-id-type="pmid">29753773</pub-id>
 </mixed-citation>
</ref>
